The Trump administration said Friday that Medicare and Medicaid won’t expand coverage of popular anti-obesity drugs, rejecting a proposal issued late last year by the Biden administration. The ...

By Michele Gershberg and Michael Erman PHILADELPHIA, March 16 (Reuters) - The CEO of Roche's Genentech unit, Ashley Magargee, said on Monday the company is striving to build a portfolio of obesity ...

American patients would be best served by several changes to policies that currently disincentivize pharmaceutical research. With the U.S. election in the rearview mirror, we have arrived at a ...

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But ...

The Federal Trade Commission said it is examining the role drug wholesalers and companies that purchase medicines for U.S. health-care providers play in shortages of generic drugs. The move follows an ...

The Biden administration unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. The announcement kicks off a controversial process ...

The Biden administration on Wednesday said it is making additional doses of the prescription flu medicine Tamiflu available from the Strategic National Stockpile so states can respond to the sharp, ...

Section 1. Purpose. During my first term, my Administration took unprecedented action to improve the well-being of the American people by restoring capacity for domestic production of critical ...

ZURICH, Feb. 24, 2025 /PRNewswire/ -- Takeda (TSE: 4502) (NYSE: TAK) announced today that the EMA has approved an additional 2 mL pre-filled pen option for TAKHZYRO® (lanadelumab) for subcutaneous ...